Aging, cytomegalovirus (CMV) and influenza vaccine responses

Human Vaccines and Immunotherapeutics

Volumn 12, Issue 3, 2016, Pages 682-690

  Frasca, Daniela ^a   Blomberg, Bonnie B ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; B cells; CMV; influenza vaccine

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; CD28 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA VACCINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIBODY;

AGING; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; CYTOTOXICITY; DENDRITIC CELL; DRUG EFFICACY; DRUG RESPONSE; HEMAGGLUTINATION INHIBITION TEST; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; IMMUNOSENESCENCE; INFLAMMATION; INFLUENZA; MONOCYTE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; T LYMPHOCYTE; TELOMERE; VACCINATION; BLOOD; CYTOMEGALOVIRUS; IMMUNOLOGY;

AGING; ANTIBODIES, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; INFLUENZA VACCINES;

EID: 84976505658     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2015.1105413     Document Type: Article

References (117)

1. A.Loerbroks, C.Stock, J.A.Bosch, D.G.Litaker, C.J.Apfelbacher. Influenza vaccination coverage among high-risk groups in 11 European countries. Eur J Public Health 2012; 22:562-8; PMID:21750011; http://dx.doi.org/10.1093/eurpub/ckr094
2. W.W.Thompson, D.K.Shay, E.Weintraub, L.Brammer, N.Cox, L.J.Anderson, K.Fukuda. Mortality associated with influenza and respiratory syncytial virus in the United States. Jama 2003; 289:179-86; PMID:12517228; http://dx.doi.org/10.1001/jama.289.2.179
3. A.S.C.Loerbroks, J.A.Bosch, D.G.Litaker, C.J.Apfelbacher. Influenza vaccination coverage among high-risk groups in 11 European countries. Eur J Public Health 2011; 22(4):562-8; PMID:21750011
4. R.K.Zimmerman, D.S.Lauderdale, S.M.Tan, D.K.Wagener. Prevalence of high-risk indications for influenza vaccine varies by age, race, and income. Vaccine 2010; 28:6470-7; PMID:20674882; http://dx.doi.org/10.1016/j.vaccine.2010.07.037
5. L.Ferrucci, J.M.Guralnik, M.Pahor, M.C.Corti, R.J.Havlik. Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older persons become severely disabled. JAMA 1997; 277:728-34; PMID:9042845; http://dx.doi.org/10.1001/jama.1997.03540330050034
6. A.S.Monto, F.Ansaldi, R.Aspinall, J.E.McElhaney, L.F.Montano, K.L.Nichol, J.Puig-Barbera, J.Schmitt, I.Stephenson. Influenza control in the 21st century: Optimizing protection of older adults. Vaccine 2009; 27:5043-53; PMID:19559118; http://dx.doi.org/10.1016/j.vaccine.2009.06.032
7. J.E.McElhaney, C.Ewen, X.Zhou, K.P.Kane, D.Xie, W.D.Hager, M.B.Barry, A.Kleppinger, Y.Wang, R.C.Bleackley. Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults. Vaccine 2009; 27:2418-25; PMID:19368783; http://dx.doi.org/10.1016/j.vaccine.2009.01.136
8. J.E.McElhaney, X.Zhou, H.K.Talbot, E.Soethout, R.C.Bleackley, D.J.Granville, G.Pawelec. The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine 2012; 30:2060-7; PMID:22289511; http://dx.doi.org/10.1016/j.vaccine.2012.01.015
9. A.J.McMichael, F.M.Gotch, G.R.Noble, P.A.Beare. Cytotoxic T-cell immunity to influenza. N Engl J Med 1983; 309:13-7; PMID:6602294; http://dx.doi.org/10.1056/NEJM198307073090103
10. X.Zhou, J.E.McElhaney. Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans. Vaccine 2011; 29:2169-77; PMID:21353149; http://dx.doi.org/10.1016/j.vaccine.2010.12.029
11. M.R.Jenkins, K.Kedzierska, P.C.Doherty, S.J.Turner. Heterogeneity of effector phenotype for acute phase and memory influenza A virus-specific CTL. J Immunol 2007; 179:64-70; http://dx.doi.org/10.4049/jimmunol.179.1.64
12. A.E.Lukacher, V.L.Braciale, T.J.Braciale. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med 1984; 160:814-26; PMID:6206190; http://dx.doi.org/10.1084/jem.160.3.814
13. S.L.Swain, R.W.Dutton, D.L.Woodland. T cell responses to influenza virus infection: effector and memory cells. Viral Immunol 2004; 17:197-209; PMID:15279699; http://dx.doi.org/10.1089/0882824041310577
14. D.J.Topham, R.A.Tripp, P.C.Doherty. CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. J Immunol 1997; 159:5197-200
15. E.L.Brincks, A.Katewa, T.A.Kucaba, T.S.Griffith, K.L.Legge. CD8 T cells utilize TRAIL to control influenza virus infection. J Immunol 2008; 181:4918-25; http://dx.doi.org/10.4049/jimmunol.181.7.4918
16. O.Finco, R.Rappuoli. Designing Vaccines for the Twenty-First Century Society. Front Immunol 2014; 5:12; PMID:24478777; http://dx.doi.org/10.3389/fimmu.2014.00012
17. D.M.Murasko, E.D.Bernstein, E.M.Gardner, P.Gross, G.Munk, S.Dran, E.Abrutyn. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp Gerontol 2002; 37:427-39; PMID:11772530; http://dx.doi.org/10.1016/S0531-5565(01)00210-8
18. D.Eto, C.Lao, D.DiToro, B.Barnett, T.C.Escobar, R.Kageyama, I.Yusuf, S.Crotty. IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PloS One 2011; 6:e17739; PMID:21423809; http://dx.doi.org/10.1371/journal.pone.0017739
19. M.A.Kroenke, D.Eto, M.Locci, M.Cho, T.Davidson, E.K.Haddad, S.Crotty. Bcl6 and Maf cooperate to instruct human follicular helper CD4 T cell differentiation. J Immunol 2012; 188:3734-44; http://dx.doi.org/10.4049/jimmunol.1103246
20. D.B.Burlington, M.L.Clements, G.Meiklejohn, M.Phelan, B.R.Murphy. Hemagglutinin-specific antibody responses in immunoglobulin G, A, and M isotypes as measured by enzyme-linked immunosorbent assay after primary or secondary infection of humans with influenza A virus. Infect Immun 1983; 41:540-5; PMID:6874068
21. J.A.McMurry, B.E.Johansson, A.S.De Groot. A call to cellular & humoral arms: enlisting cognate T cell help to develop broad-spectrum vaccines against influenza A. Hum Vaccin 2008; 4:148-57; PMID:18382131; http://dx.doi.org/10.4161/hv.4.2.5169
22. J.Wrammert, K.Smith, J.Miller, W.A.Langley, K.Kokko, C.Larsen, N.Y.Zheng, I.Mays, L.Garman, C.Helms, et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008; 453:667-71; PMID:18449194; http://dx.doi.org/10.1038/nature06890
23. D.Corti, A.L.Suguitan, Jr., D.Pinna, C.Silacci, B.M.Fernandez-Rodriguez, F.Vanzetta, C.Santos, C.J.Luke, F.J.Torres-Velez, N.J.Temperton, et al. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J Clin Invest 2010; 120:1663-73; PMID:20389023; http://dx.doi.org/10.1172/JCI41902
24. K.Goodwin, C.Viboud, L.Simonsen. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006; 24:1159-69; PMID:16213065; http://dx.doi.org/10.1016/j.vaccine.2005.08.105
25. J.E.McElhaney. Influenza vaccine responses in older adults. Ageing Res Rev 2010; 10(3):379-88; PMID:21055484
26. J.E.McElhaney, R.B.Effros. Immunosenescence: what does it mean to health outcomes in older adults? Curr Opin Immunol 2009; 21:418-24; PMID:19570667; http://dx.doi.org/10.1016/j.coi.2009.05.023
27. L.Simonsen, R.J.Taylor, C.Viboud, M.A.Miller, L.A.Jackson. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007; 7:658-66; PMID:17897608; http://dx.doi.org/10.1016/S1473-3099(07)70236-0
28. P.V.Targonski, R.M.Jacobson, G.A.Poland. Immunosenescence: role and measurement in influenza vaccine response among the elderly. Vaccine 2007; 25:3066-9; PMID:17275144; http://dx.doi.org/10.1016/j.vaccine.2007.01.025
29. A.E.Ahmed, K.G.Nicholson, J.S.Nguyen-Van-Tam. Reduction in mortality associated with influenza vaccine during 1989–90 epidemic. Lancet 1995; 346:591-5; PMID:7651002; http://dx.doi.org/10.1016/S0140-6736(95)91434-X
30. W.A.Keitel, T.R.Cate, R.B.Couch. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am J Epidemiol 1988; 127:353-64; PMID:3337087
31. W.W.Thompson, D.K.Shay, E.Weintraub, L.Brammer, C.B.Bridges, N.J.Cox, K.Fukuda. Influenza-associated hospitalizations in the United States. JAMA 2004; 292:1333-40; PMID:15367555; http://dx.doi.org/10.1001/jama.292.11.1333
32. P.A.Gross, A.W.Hermogenes, H.S.Sacks, J.Lau, R.A.Levandowski. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995; 123:518-27; PMID:7661497; http://dx.doi.org/10.7326/0003-4819-123-7-199510010-00008
33. L.Simonsen, M.J.Clarke, L.B.Schonberger, N.H.Arden, N.J.Cox, K.Fukuda. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1998; 178:53-60; PMID:9652423; http://dx.doi.org/10.1086/515616
34. T.Vu, S.Farish, M.Jenkins, H.Kelly. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002; 20:1831-6; PMID:11906772; http://dx.doi.org/10.1016/S0264-410X(02)00041-5
35. J.Legrand, E.Vergu, A.Flahault. Real-time monitoring of the influenza vaccine field effectiveness. Vaccine 2006; 24:6605-11; PMID:16806607; http://dx.doi.org/10.1016/j.vaccine.2006.05.063
36. K.L.Nichol, K.L.Margolis, J.Wuorenma, T.Von Sternberg. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331:778-84; PMID:8065407; http://dx.doi.org/10.1056/NEJM199409223311206
37. H.I.Nakaya, J.Wrammert, E.K.Lee, L.Racioppi, S.Marie-Kunze, W.N.Haining, A.R.Means, S.P.Kasturi, N.Khan, G.M.Li, et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 2011; 12:786-95; PMID:21743478; http://dx.doi.org/10.1038/ni.2067
38. G.Obermoser, S.Presnell, K.Domico, H.Xu, Y.Wang, E.Anguiano, L.Thompson-Snipes, R.Ranganathan, B.Zeitner, A.Bjork, et al. Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity 2013; 38:831-44; PMID:23601689; http://dx.doi.org/10.1016/j.immuni.2012.12.008
39. J.J.Goronzy, J.W.Fulbright, C.S.Crowson, G.A.Poland, W.M.O'Fallon, C.M.Weyand. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 2001; 75:12182-7; PMID:11711609; http://dx.doi.org/10.1128/JVI.75.24.12182-12187.2001
40. S.Gupta, R.Bi, K.Su, L.Yel, S.Chiplunkar, S.Gollapudi. Characterization of naive, memory and effector CD8+ T cells: effect of age. Exp Gerontol 2004; 39:545-50; PMID:15050289; http://dx.doi.org/10.1016/j.exger.2003.08.013
41. G.Pawelec, Y.Barnett, R.Forsey, D.Frasca, A.Globerson, J.McLeod, C.Caruso, C.Franceschi, T.Fulop, S.Gupta, et al. T cells and aging, January 2002 update. Front Biosci 2002; 7:d1056-183; PMID:11991846
42. A.Sridharan, M.Esposo, K.Kaushal, J.Tay, K.Osann, S.Agrawal, S.Gupta, A.Agrawal. Age-associated impaired plasmacytoid dendritic cell functions lead to decreased CD4 and CD8 T cell immunity. Age 2011; 33:363-76; PMID:20953722; http://dx.doi.org/10.1007/s11357-010-9191-3
43. Y.Chong, H.Ikematsu, K.Yamaji, M.Nishimura, S.Nabeshima, S.Kashiwagi, J.Hayashi. CD27(+) (memory) B cell decrease and apoptosis-resistant CD27(-) (naive) B cell increase in aged humans: implications for age-related peripheral B cell developmental disturbances. Int Immunol 2005; 17:383-90; PMID:15724062; http://dx.doi.org/10.1093/intimm/dxh218
44. D.Frasca, A.Diaz, M.Romero, A.M.Landin, M.Phillips, S.C.Lechner, J.G.Ryan, B.B.Blomberg. Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans. Vaccine 2010; 28:8077-84; PMID:20974306; http://dx.doi.org/10.1016/j.vaccine.2010.10.023
45. D.Frasca, A.Diaz, M.Romero, N.V.Mendez, A.M.Landin, J.G.Ryan, B.B.Blomberg. Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine. Vaccine 2013; 31(35):3603-10; PMID:23711934
46. D.Frasca, A.Diaz, M.Romero, M.Phillips, N.V.Mendez, A.M.Landin, B.B.Blomberg. Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine. Int Immunol 2012; 24:175-82; PMID:22281510; http://dx.doi.org/10.1093/intimm/dxr123
47. D.Frasca, A.M.Landin, S.C.Lechner, J.G.Ryan, R.Schwartz, R.L.Riley, B.B.Blomberg. Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J Immunol 2008; 180:5283-90; http://dx.doi.org/10.4049/jimmunol.180.8.5283
48. Y.Shi, T.Yamazaki, Y.Okubo, Y.Uehara, K.Sugane, K.Agematsu. Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell. J Immunol 2005; 175:3262-7; http://dx.doi.org/10.4049/jimmunol.175.5.3262
49. D.Frasca, B.B.Blomberg. Effects of aging on B cell function. Curr Opin Immunol 2009; 21:425-30; PMID:19608393; http://dx.doi.org/10.1016/j.coi.2009.06.001
50. P.J.Linton, K.Dorshkind. Age-related changes in lymphocyte development and function. Nat Immunol 2004; 5:133-9; PMID:14749784; http://dx.doi.org/10.1038/ni1033
51. R.Solana, G.Pawelec, R.Tarazona. Aging and innate immunity. Immunity 2006; 24:491-4; PMID:16713963; http://dx.doi.org/10.1016/j.immuni.2006.05.003
52. Y.Jing, E.Shaheen, R.R.Drake, N.Chen, S.Gravenstein, Y.Deng. Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood. Hum Immunol 2009; 70:777-84; PMID:19596035; http://dx.doi.org/10.1016/j.humimm.2009.07.005
53. A.Panda, F.Qian, S.Mohanty, D.van Duin, F.K.Newman, L.Zhang, S.Chen, V.Towle, R.B.Belshe, E.Fikrig, et al. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol 2010; 184:2518-27; http://dx.doi.org/10.4049/jimmunol.0901022
54. J.Olsson, A.Wikby, B.Johansson, S.Lofgren, B.O.Nilsson, F.G.Ferguson. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 2000; 121:187-201; PMID:11164473; http://dx.doi.org/10.1016/S0047-6374(00)00210-4
55. G.Pawelec, E.Derhovanessian, A.Larbi, J.Strindhall, A.Wikby. Cytomegalovirus and human immunosenescence. Rev Med Virol 2009; 19:47-56; PMID:19035529; http://dx.doi.org/10.1002/rmv.598
56. K.Najarro, H.Nguyen, G.Chen, M.Xu, S.Alcorta, X.Yao, L.Zukley, E.J.Metter, T.Truong, Y.Lin, et al. Telomere Length as an Indicator of the Robustness of B- and T-Cell Response to Influenza in Older Adults. J Infect Dis 2015; 212(8):1261-9.
57. A.N.Vallejo. CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev 2005; 205:158-69; PMID:15882352; http://dx.doi.org/10.1111/j.0105-2896.2005.00256.x
58. E.Derhovanessian, H.Theeten, K.Hahnel, P.Van Damme, N.Cools, G.Pawelec. Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination. Vaccine 2013; 31:685-90; PMID:23196209; http://dx.doi.org/10.1016/j.vaccine.2012.11.041
59. M.Saurwein-Teissl, T.L.Lung, F.Marx, C.Gschosser, E.Asch, I.Blasko, W.Parson, G.Bock, D.Schonitzer, E.Trannoy, et al. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 2002; 168:5893-9; http://dx.doi.org/10.4049/jimmunol.168.11.5893
60. A.N.Vallejo, C.M.Weyand, J.J.Goronzy. T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. Trends Mol Med 2004; 10:119-24; PMID:15102354; http://dx.doi.org/10.1016/j.molmed.2004.01.002
61. A.M.Wertheimer, M.S.Bennett, B.Park, J.L.Uhrlaub, C.Martinez, V.Pulko, N.L.Currier, D.Nikolich-Zugich, J.Kaye, J.Nikolich-Zugich. Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans. J Immunol 2014; 192:2143-55; http://dx.doi.org/10.4049/jimmunol.1301721
62. O.Acuto, F.Michel. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat Rev Immunol 2003; 3:939-51; PMID:14647476; http://dx.doi.org/10.1038/nri1248
63. D.E.Lewis, L.Yang, W.Luo, X.Wang, J.R.Rodgers. HIV-specific cytotoxic T lymphocyte precursors exist in a CD28-CD8+ T cell subset and increase with loss of CD4 T cells. Aids 1999; 13:1029-33; PMID:10397532; http://dx.doi.org/10.1097/00002030-199906180-00005
64. V.M.Martinez-Taboada, J.J.Goronzy, C.M.Weyand. Clonally expanded CD8 T cells in patients with polymyalgia rheumatica and giant cell arteritis. Clin Immunol Immunopathol 1996; 79:263-70; PMID:8635285; http://dx.doi.org/10.1006/clin.1996.0078
65. G.A.Neil, R.W.Summers, B.A.Cheyne, C.Carpenter, W.L.Huang, T.J.Waldschmidt. Analysis of T-lymphocyte subpopulations in inflammatory bowel diseases by three-color flow cytometry. Dig Dis Sci 1994; 39:1900-8; PMID:8082496; http://dx.doi.org/10.1007/BF02088123
66. D.Schmidt, J.J.Goronzy, C.M.Weyand. CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 1996; 97:2027-37; PMID:8621791; http://dx.doi.org/10.1172/JCI118638
67. S.E.Ferguson, S.Han, G.Kelsoe, C.B.Thompson. CD28 is required for germinal center formation. J Immunol 1996; 156:4576-81.
68. A.Shahinian, K.Pfeffer, K.P.Lee, T.M.Kundig, K.Kishihara, A.Wakeham, K.Kawai, P.S.Ohashi, C.B.Thompson, T.W.Mak. Differential T cell costimulatory requirements in CD28-deficient mice. Science 1993; 261:609-12; PMID:7688139; http://dx.doi.org/10.1126/science.7688139
69. A.Lanna, S.M.Henson, D.Escors, A.N.Akbar. The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells. Nat Immunol 2014; 15:965-72; PMID:25151490; http://dx.doi.org/10.1038/ni.2981
70. S.C.Johnson, P.S.Rabinovitch, M.Kaeberlein. mTOR is a key modulator of ageing and age-related disease. Nature 2013; 493:338-45; PMID:23325216; http://dx.doi.org/10.1038/nature11861
71. L.Ferrucci, A.Corsi, F.Lauretani, S.Bandinelli, B.Bartali, D.D.Taub, J.M.Guralnik, D.L.Longo. The origins of age-related proinflammatory state. Blood 2005; 105:2294-9; PMID:15572589; http://dx.doi.org/10.1182/blood-2004-07-2599
72. C.Franceschi, M.Bonafe, S.Valensin, F.Olivieri, M.De Luca, E.Ottaviani, G.De Benedictis. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000; 908:244-54; PMID:10911963; http://dx.doi.org/10.1111/j.1749-6632.2000.tb06651.x
73. C.Franceschi, M.Capri, D.Monti, S.Giunta, F.Olivieri, F.Sevini, M.P.Panourgia, L.Invidia, L.Celani, M.Scurti, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007; 128:92-105; PMID:17116321; http://dx.doi.org/10.1016/j.mad.2006.11.016
74. C.Franceschi, S.Valensin, M.Bonafe, G.Paolisso, A.I.Yashin, D.Monti, G.De Benedictis. The network and the remodeling theories of aging: historical background and new perspectives. Exp Gerontol 2000; 35:879-96; PMID:11053678; http://dx.doi.org/10.1016/S0531-5565(00)00172-8
75. D.van Duin, H.G.Allore, S.Mohanty, S.Ginter, F.K.Newman, R.B.Belshe, R.Medzhitov, A.C.Shaw. Prevaccine determination of the expression of costimulatory B7 molecules in activated monocytes predicts influenza vaccine responses in young and older adults. J Infect Dis 2007; 195:1590-7; PMID:17471428; http://dx.doi.org/10.1086/516788
76. E.Derhovanessian, A.Larbi, G.Pawelec. Biomarkers of human immunosenescence: impact of Cytomegalovirus infection. Curr Opin Immunol 2009; 21:440-5; PMID:19535233; http://dx.doi.org/10.1016/j.coi.2009.05.012
77. D.Frasca, A.Diaz, M.Romero, A.M.Landin, B.B.Blomberg. High TNF-α levels in resting B cells negatively correlate with their response. Exp Gerontol 2014; 54:116-22; PMID:24440385; http://dx.doi.org/10.1016/j.exger.2014.01.004
78. D.Frasca, A.Diaz, M.Romero, A.M.Landin, B.B.Blomberg. Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine. Vaccine 2015; 33:1433-9; PMID:25659271; http://dx.doi.org/10.1016/j.vaccine.2015.01.071
79. D.Frasca, A.Diaz, M.Romero, N.V.Mendez, A.M.Landin, J.G.Ryan, B.B.Blomberg. Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine. Vaccine 2013; 31:3603-10; PMID:23711934; http://dx.doi.org/10.1016/j.vaccine.2013.05.003
80. C.E.Sayegh, M.W.Quong, Y.Agata, C.Murre. E-proteins directly regulate expression of activation-induced deaminase in mature B cells. Nat Immunol 2003; 4:586-93; PMID:12717431; http://dx.doi.org/10.1038/ni923
81. D.Frasca, A.M.Landin, J.P.Alvarez, P.J.Blackshear, R.L.Riley, B.B.Blomberg. Tristetraprolin, a negative regulator of mRNA stability, is increased in old B cells and is involved in the degradation of E47 mRNA. J Immunol 2007; 179:918-27; http://dx.doi.org/10.4049/jimmunol.179.2.918
82. P.Goebel, N.Janney, J.R.Valenzuela, W.J.Romanow, C.Murre, A.J.Feeney. Localized gene-specific induction of accessibility to V(D)J recombination induced by E2A and early B cell factor in nonlymphoid cells. J Exp Med 2001; 194:645-56; PMID:11535632; http://dx.doi.org/10.1084/jem.194.5.645
83. M.W.Quong, D.P.Harris, S.L.Swain, C.Murre. E2A activity is induced during B-cell activation to promote immunoglobulin class switch recombination. EMBO J 1999; 18:6307-18; PMID:10562543; http://dx.doi.org/10.1093/emboj/18.22.6307
84. M.W.Quong, W.J.Romanow, C.Murre. E protein function in lymphocyte development. Annu Rev Immunol 2002; 20:301-22; PMID:11861605; http://dx.doi.org/10.1146/annurev.immunol.20.092501.162048
85. C.E.Sayegh, M.W.Quong, Y.Agata, C.Murre. E-proteins directly regulate expression of activation-induced deaminase in mature B cells. Nat Immunol 2003; 4:586-93; PMID:12717431; http://dx.doi.org/10.1038/ni923
86. M.Schlissel, A.Voronova, D.Baltimore. Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line. Genes Dev 1991; 5:1367-76; PMID:1714414; http://dx.doi.org/10.1101/gad.5.8.1367
87. S.Khurana, D.Frasca, B.Blomberg, H.Golding. AID activity in B cells strongly correlates with polyclonal antibody affinity maturation in-vivo following pandemic 2009-H1N1 vaccination in humans. PLoS Pathog 2012; 8:e1002920; PMID:23028320; http://dx.doi.org/10.1371/journal.ppat.1002920
88. S.D.Boyd, Y.Liu, C.Wang, V.Martin, D.K.Dunn-Walters. Human lymphocyte repertoires in ageing. Curr Opin Immunol 2013; 25:511-5; PMID:23992996; http://dx.doi.org/10.1016/j.coi.2013.07.007
89. K.L.Gibson, Y.C.Wu, Y.Barnett, O.Duggan, R.Vaughan, E.Kondeatis, B.O.Nilsson, A.Wikby, D.Kipling, D.K.Dunn-Walters. B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell 2009; 8:18-25; PMID:18986373; http://dx.doi.org/10.1111/j.1474-9726.2008.00443.x
90. A.Ademokun, Y.C.Wu, V.Martin, R.Mitra, U.Sack, H.Baxendale, D.Kipling, D.K.Dunn-Walters. Vaccination-induced changes in human B-cell repertoire and pneumococcal IgM and IgA antibody at different ages. Aging Cell 2011; 10:922-30; PMID:21726404; http://dx.doi.org/10.1111/j.1474-9726.2011.00732.x
91. N.Jiang, J.He, J.A.Weinstein, L.Penland, S.Sasaki, X.S.He, C.L.Dekker, N.Y.Zheng, M.Huang, M.Sullivan, et al. Lineage structure of the human antibody repertoire in response to influenza vaccination. Sci Transl Med 2013; 5:171ra19; PMID:23390249; http://dx.doi.org/10.1126/scitranslmed.3004794
92. D.K.Dunn-Walters, A.A.Ademokun. B cell repertoire and ageing. Curr Opin Immunol 2010; 22:514-20; PMID:20537880; http://dx.doi.org/10.1016/j.coi.2010.04.009
93. F.E.Lund, M.Hollifield, K.Schuer, J.L.Lines, T.D.Randall, B.A.Garvy. B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection. J Immunol 2006; 176:6147-54; http://dx.doi.org/10.4049/jimmunol.176.10.6147
94. L.C.Menard, L.A.Minns, S.Darche, D.W.Mielcarz, D.M.Foureau, D.Roos, F.Dzierszinski, L.H.Kasper, D.Buzoni-Gatel. B cells amplify IFN-gamma production by T cells via a TNF-α-mediated mechanism. J Immunol 2007; 179:4857-66; http://dx.doi.org/10.4049/jimmunol.179.7.4857
95. W.Wojciechowski, D.P.Harris, F.Sprague, B.Mousseau, M.Makris, K.Kusser, T.Honjo, K.Mohrs, M.Mohrs, T.Randall, et al. Cytokine-producing effector B cells regulate type 2 immunity to H. polygyrus. Immunity 2009; 30:421-33; PMID:19249230; http://dx.doi.org/10.1016/j.immuni.2009.01.006
96. J.Banchereau, F.Briere, C.Caux, J.Davoust, S.Lebecque, Y.J.Liu, B.Pulendran, K.Palucka. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18:767-811; PMID:10837075; http://dx.doi.org/10.1146/annurev.immunol.18.1.767
97. J.Banchereau, R.M.Steinman. Dendritic cells and the control of immunity. Nature 1998; 392:245-52; PMID:9521319; http://dx.doi.org/10.1038/32588
98. S.Mohanty, S.R.Joshi, I.Ueda, J.Wilson, T.P.Blevins, B.Siconolfi, H.Meng, L.Devine, K.Raddassi, S.Tsang, et al. Prolonged Proinflammatory Cytokine Production in Monocytes Modulated by Interleukin 10 After Influenza Vaccination in Older Adults. J Infect Dis 2014; 211(7):1174-84.
99. G.Pawelec, J.E.McElhaney, A.E.Aiello, E.Derhovanessian. The impact of CMV infection on survival in older humans. Curr Opin Immunol 2012; 24:507-11; PMID:22541724; http://dx.doi.org/10.1016/j.coi.2012.04.002
100. G.Pawelec, E.Derhovanessian. Role of CMV in immune senescence. Virus Res 2011; 157:175-9; PMID:20869407; http://dx.doi.org/10.1016/j.virusres.2010.09.010
101. A.Wikby, B.O.Nilsson, R.Forsey, J.Thompson, J.Strindhall, S.Lofgren, J.Ernerudh, G.Pawelec, F.Ferguson, B.Johansson. The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late life functioning. Mech Ageing Dev 2006; 127:695-704; PMID:16750842; http://dx.doi.org/10.1016/j.mad.2006.04.003
102. F.Haspot, A.Lavault, C.Sinzger, K.Laib Sampaio, Y.D.Stierhof, P.Pilet, C.Bressolette-Bodin, F.Halary. Human cytomegalovirus entry into dendritic cells occurs via a macropinocytosis-like pathway in a pH-independent and cholesterol-dependent manner. PloS One 2012; 7:e34795; PMID:22496863; http://dx.doi.org/10.1371/journal.pone.0034795
103. R.B.FreemanJr. The ‘indirect’ effects of cytomegalovirus infection. Am J Transplant 2009; 9:2453-8; PMID:19843027; http://dx.doi.org/10.1111/j.1600-6143.2009.02824.x
104. S.Prosch, K.Staak, J.Stein, C.Liebenthal, T.Stamminger, H.D.Volk, D.H.Kruger. Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB. Virology 1995; 208:197-206; PMID:11831701; http://dx.doi.org/10.1006/viro.1995.1143
105. P.Trzonkowski, J.Mysliwska, E.Szmit, J.Wieckiewicz, K.Lukaszuk, L.B.Brydak, M.Machala, A.Mysliwski. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination–an impact of immunosenescence. Vaccine 2003; 21:3826-36; PMID:12922116; http://dx.doi.org/10.1016/S0264-410X(03)00309-8
106. J.E.Turner, J.P.Campbell, K.M.Edwards, L.J.Howarth, G.Pawelec, S.Aldred, P.Moss, M.T.Drayson, V.E.Burns, J.A.Bosch. Rudimentary signs of immunosenescence in Cytomegalovirus-seropositive healthy young adults. Age 2014; 36:287-97; PMID:23846127; http://dx.doi.org/10.1007/s11357-013-9557-4
107. E.Derhovanessian, A.B.Maier, K.Hahnel, J.E.McElhaney, E.P.Slagboom, G.Pawelec. Latent infection with cytomegalovirus is associated with poor memory CD4 responses to influenza A core proteins in the elderly. J Immunol 2014; 193:3624-31; http://dx.doi.org/10.4049/jimmunol.1303361
108. W.P.den Elzen, A.C.Vossen, H.J.Cools, R.G.Westendorp, A.C.Kroes, J.Gussekloo. Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities. Vaccine 2011; 29:4869-74; PMID:21497631; http://dx.doi.org/10.1016/j.vaccine.2011.03.086
109. D.Furman, V.Jojic, S.Sharma, S.S.Shen-Orr, C.J.Angel, S.Onengut-Gumuscu, B.A.Kidd, H.T.Maecker, P.Concannon, C.L.Dekker, et al. Cytomegalovirus infection enhances the immune response to influenza. Sci Transl Med 2015; 7:281ra43; PMID:25834109; http://dx.doi.org/10.1126/scitranslmed.aaa2293
110. A.Pera, C.Campos, A.Corona, B.Sanchez-Correa, R.Tarazona, A.Larbi, R.Solana. CMV latent infection improves CD8+ T response to SEB due to expansion of polyfunctional CD57+ cells in young individuals. PloS One 2014; 9:e88538; PMID:24533103; http://dx.doi.org/10.1371/journal.pone.0088538
111. J.W.Critchfield, D.Lemongello, D.H.Walker, J.C.Garcia, D.M.Asmuth, R.B.Pollard, B.L.Shacklett. Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection. J Virol 2007; 81:5460-71; PMID:17344302; http://dx.doi.org/10.1128/JVI.02535-06
112. M.L.Precopio, M.R.Betts, J.Parrino, D.A.Price, E.Gostick, D.R.Ambrozak, T.E.Asher, D.C.Douek, A.Harari, G.Pantaleo, et al. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. J Exp Med 2007; 204:1405-16; PMID:17535971; http://dx.doi.org/10.1084/jem.20062363
113. E.Derhovanessian, A.B.Maier, K.Hahnel, H.Zelba, A.J.de Craen, H.Roelofs, E.P.Slagboom, R.G.Westendorp, G.Pawelec. Lower proportion of naive peripheral CD8+ T cells and an unopposed pro-inflammatory response to human Cytomegalovirus proteins in vitro are associated with longer survival in very elderly people. Age 2013; 35:1387-99; PMID:22661297; http://dx.doi.org/10.1007/s11357-012-9425-7
114. C.Wang, Y.Liu, L.T.Xu, K.J.Jackson, K.M.Roskin, T.D.Pham, J.Laserson, E.L.Marshall, K.Seo, J.Y.Lee, et al. Effects of aging, cytomegalovirus infection, and EBV infection on human B cell repertoires. J Immunol 2014; 192:603-11; http://dx.doi.org/10.4049/jimmunol.1301384
115. M.Guma, A.Angulo, C.Vilches, N.Gomez-Lozano, N.Malats, M.Lopez-Botet. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004; 104:3664-71; PMID:15304389; http://dx.doi.org/10.1182/blood-2004-05-2058
116. M.A.Caligiuri. Human natural killer cells. Blood 2008; 112:461-9; PMID:18650461; http://dx.doi.org/10.1182/blood-2007-09-077438
117. C.M.Nielsen, M.J.White, C.Bottomley, C.Lusa, A.Rodriguez-Galan, S.E.Turner, M.R.Goodier, E.M.Riley. Impaired NK Cell Responses to Pertussis and H1N1 Influenza Vaccine Antigens in Human Cytomegalovirus-Infected Individuals. J Immunol 2015; 194:4657-67; http://dx.doi.org/10.4049/jimmunol.1403080